Introduction: Recently, biologic agents have been added to bone graft materials in sinus-augmentation surgeries to accelerate the rate of regeneration. One such agent is recombinant human bone morphogenetic protein-2 (rhBMP-2) using an absorbable collagen sponge (ACS) as a carrier. Researchers have previously shown that, not only can rhBMP-2 be successfully added to an allograft, but that the amount of ACS used is directly related to an increase in future graft shrinkage. There are limited data on adding rhBMP-2 to an allograft mixture without any ACS. Hence, the objective of this case report is to provide the first histomorphometric analysis using rhBMP-2 with allograft mixture without an ACS in an effort to reduce graft shrinkage.
Background
The restoration of the posterior maxilla can often be complicated by the maxillary sinus. Accelerated bone resorption and sinus pneumatization after tooth loss may result in insufficient native bone height to allow for the proper placement of an implant without compromising its length. Although the current success rates of implants placed in previously augmented maxillary sinuses are already high (90% 1 to 91.5% 2 ), the addition of biologic agents with bone graft materials has also been investigated. [3] [4] [5] [6] [7] [8] Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-b superfamily and are osteoinductive. 9 When added to sinus-augmentation procedures, they have been shown to not only improve the quality of the bone graft significantly, but also to accelerate the healing process 8, [10] [11] [12] in a dose-dependent manner. 13, 14 Of concern, recombinant human BMP-2 (rhBMP-2) is only approved by the Food and Drug Administration for use with an absorbable collagen sponge (ACS), but researchers have found a direct relationship between the number of sponges used and the degree of shrinkage of the graft material. 8 If the only approved carrier for rhBMP-2 has poor space maintaining properties in addition to a high resorption rate, then the amount of successful bony augmentation that can be expected is greatly limited. In the current case of a lateral window maxillary sinus augmentation, the authors hoped to optimally reduce the degree of shrinkage by foregoing the use of an ACS and directly adding the rhBMP-2 solution to the allograft mixture.
Clinical Presentation
On March 2, 2009, a 63-year-old male patient presented to the Dental Faculty Associates clinic at the University of Michigan School of Dentistry, Ann Arbor, Michigan, to restore the edentulous space in his posterior upper right sextant. The patient signed a written informed consent for all treatment. His medical history was significant for osteoarthritis in his hands and a systemic allergy to penicillin. His current medications were daily doses of 20 mg atorvastatin, 325 mg aspirin, and 800 mg ibuprofen. The patient was classified as American Society of Anesthesiologists Class II physical status. 15 At the initial appointment, the patient presented with a fixed partial denture for tooth sites #2 through #5, with tooth sites #2, #4, and #5 serving as abutments and tooth site #5 connected through a semirigid connector. Tooth site #2 had fractured 3 mm subgingivally and was deemed nonrestorable. The bridge was sectioned distal to tooth site #4, and tooth site #2 was extracted with no complications; no ridge preservation was performed at this time. The right sinus demonstrated significant pneumatization and ridge resorption as demonstrated in the pretreatment panoramic radiograph (Fig. 1) ; in the area of tooth sites #2 and #3, mean ridge width was 9.6 mm, and mean ridge height was 3.8 mm.
Case Management
Seven weeks after extraction, the patient was scheduled for surgery. On the day of surgery, the patient took 500 mg azithromycin, 800 mg ibuprofen, and 180 mg pseudoephedrine. The patient was placed under moderate intravenous sedation. Local anesthesia was achieved using three carpules of 2% lidocaine with 1:50,000 epinephrine for local infiltrations. A full-thickness flap was raised and a circular lateral window 10 mm in diameter was created using high-speed electric and piezoelectric hand pieces 3 mm apical to the estimated floor of the right maxillary sinus (Fig. 2) . The Schneiderian membrane was elevated, and an absorbable collagen membrane ‡ was placed against it to: 1) protect the membrane during bone graft placement; 2) seal any membrane perforations that may exist; and 3) allow for better viewing for graft placement (Fig. 3) .
A 4:1 mixed ratio of human allograft x cortical (large particle: 1 to 2 mm)/cancellous (small particle: 250 to 850 mm) mixture was hydrated with 1.05 mg rhBMP-2 ‖ mixed with 1 mL sterile water. The bone graft mixture was lightly packed into the sinus cavity (Fig. 4) . Small-particle mineralized cancellous allograft was used on the most lateral portion of the window to allow for optimal healing (Fig. 5) . A second absorbable collagen membrane was trimmed to cover the outside window overlapping the edges by at least 2 to 3 mm and fixated under the palatal flap (Figs. 6 and 7) . After surgery, medication was prescribed for the patient, including: 1) six tablets of 250 mg azithromycin, two tablets to be taken on the first day and then one tablet for the remaining 4 days; 2) 20 tablets of 800 mg ibuprofen, one tablet to be taken twice daily as needed for pain; 3) nine tablets of 2 mg dexamethasone, four tablets to be taken on the first day, two tablets on the second and third days, and one tablet on the fourth day; and 4) 25 tablets of 10/1,000 mg hydrocodone/acetaminophen, one tablet to be taken three times per day as needed for pain. Healing was uneventful, and sutures were removed after 2 weeks. Panoramic radiographs were taken at the 2-week and 6-month postoperative visits (Figs. 8 and 9 ).
Six months after the sinus augmentation, implant surgery was performed under local anesthesia. A flap was reflected and showed good bone formation (Fig. 10) . Trephine bone core biopsies were collected, and two implants { were placed at tooth sites #2 and #3 (5.0 Â 13 and 4.3 Â 13 mm, respectively), achieving excellent primary stability. The patient was placed on a similar regimen of azithromycin and ibuprofen as with the sinus-augmentation surgery.
Clinical Outcomes
Both core biopsies underwent histologic analyses. Masson trichrome staining method demonstrated the maturation process of the graft (Fig. 11) . Immature osteoid is stained red, whereas mature mineralized bone is stained blue. Because there was a significantly greater proportion of mineralized bone (suggesting higher bone density), it can be inferred that the graft underwent regeneration, new bone formation, and maturation. Hematoxylin and eosin (H&E) staining (Fig. 12) revealed osteocytes within lacunae of the mineralized bone, indicating the viability of the mature bone.
Second-stage surgery was performed after 5 months with sound stability of both implants. Three months later, splinted porcelain fused to metal (PFM) crowns were cemented on implants #2 and #3, a PFM crown was cemented on implant #4, and implant #5 was restored with a composite restoration. Final restoration was completed 6 months after implant placement and periapical radiographs were taken (Fig. 13) .
Discussion
Comparing panoramic radiographs at 2 weeks and 6 months after the sinus-augmentation procedure revealed minimal density change. Histologic analysis showed significant graft maturation. As such, it appears as though adding rhBMP-2 directly to the allograft mixture is a viable method for maxillary sinus augmentations. However, larger and long-term randomized controlled trials are needed for proper quantitative analysis and to determine its long-term predictability. j To truly claim the graft regenerated at an accelerated rate with reduced shrinkage attributable to the addition of rhBMP-2 to the allograft, biopsies would need to be taken earlier after the grafting procedure and compared with controls.
